These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3220610)
21. Effect of food on bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms: Part I. Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):148-52. PubMed ID: 3699941 [TBL] [Abstract][Full Text] [Related]
22. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose]. Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255 [TBL] [Abstract][Full Text] [Related]
23. Influence of pentoxifylline on steady-state theophylline serum concentrations from sustained-release formulations. Ellison MJ; Horner RD; Willis SE; Cummings DM Pharmacotherapy; 1990; 10(6):383-6. PubMed ID: 2287557 [TBL] [Abstract][Full Text] [Related]
24. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses. Schuppan D; Molz KH; Staib AH; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238 [TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics of two theophylline sustained-release preparations in healthy humans]. Keller A; Schulz HU Arzneimittelforschung; 1994 Nov; 44(11):1233-6. PubMed ID: 7848337 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system. González MA; Kisicki J; Straughn AB Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257 [TBL] [Abstract][Full Text] [Related]
28. Steady-state pharmacokinetics of two sustained-release theophylline products during once-daily and twice-daily dosing. Armstrong EP; Nako N; Plezia PM; Kramer TH; Jones WN Clin Pharm; 1987 Oct; 6(10):800-4. PubMed ID: 3505842 [No Abstract] [Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (theolair and Theolair retard) in normals and asthmatics. Part I: pharmacokinetics. Utama I; Kreukniet J; Meering PG; Maes RA Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):287-91. PubMed ID: 6885202 [TBL] [Abstract][Full Text] [Related]
30. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy. Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380 [TBL] [Abstract][Full Text] [Related]
31. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily. Götz J; Sauter R; Steinijans VW; Jonkman JH Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575 [TBL] [Abstract][Full Text] [Related]
32. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels. Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891 [TBL] [Abstract][Full Text] [Related]
33. Influence of food on bioavailability from two controlled-release granules of theophylline. Tada H; Ishikawa M; Sato E; Suzuki T; Unno K; Miura K; Ohmiya Y; Nakai K J Clin Pharm Ther; 1989 Apr; 14(2):145-51. PubMed ID: 2722977 [TBL] [Abstract][Full Text] [Related]
34. Food interaction study of a new theophylline (Egifilin) 200 and 400 mg retard tablet in healthy volunteers. Urmös I; Grézal G; Balogh Nemes K; Szállási T; Drabant S; Csörgo M; Klebovich I Int J Clin Pharmacol Ther; 1997 Feb; 35(2):65-70. PubMed ID: 9147710 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic properties of a new sustained-release theophylline preparation. Dahlqvist R; Billing B Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927 [TBL] [Abstract][Full Text] [Related]
36. [The effect of food on theophylline absorption]. Pabst G; Weber W; Müller M; Barkworth MF Arzneimittelforschung; 1998 May; 48(5A):569-73. PubMed ID: 9676346 [TBL] [Abstract][Full Text] [Related]
38. Night-time pharmacokinetics of once a day theophylline: a steady state comparison of three preparations. Karttunen P; Tukiainen H; Nykänen S; Saano V Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):161-5. PubMed ID: 3997302 [TBL] [Abstract][Full Text] [Related]
39. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children. Logvinoff MM; Weinstein DB; Watts MT; Seifert B Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic properties of sustained-release theophylline (Theolair-SR) in relation to timing of doses after low-fat meals. Welsh PW; O'Connell EJ; Sachs MI; Moyer TP; Wick KA; Harrison LI; McCarville SE; Kvam DC Ann Allergy; 1989 May; 62(5):396-400. PubMed ID: 2719348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]